PQ magazine is for part qualified accountants.
Read the latest web issue here – if you like what you see sign up today
Time to act on smart drug
22 May 2018
The UK’s top universities have been accused of turning a blind eye to the growing use and danger of their students turning to ‘smart drugs’ to help boost exam performance.
It appears just one student at the 24 Russell Group elite universities has been caught, according to a new survey. This is despite claims from many academics saying the use of smart drugs has become rife, especially at key examination times.
These nootropics, such as Modafinil, are easily available online and are used to help treat ADHD and narcolepsy. They are marketed to students who need to put in long hours of revision and a medical alternative to energy drinks.
Recent surveys have found that up 35% of students admit to have used the study drugs. The worry is taking these drugs has been normalised and will be taken by many going on to sit professional accountancy exams.
Subscribe to RSS